SARS-CoV-2 Seroprevalence and Risk Factors Among Close Contacts
Intensive health surveillance of close contracts of patients with COVID-19 provided a rare opportunity to determine asymptomatic attack rates and SARS-CoV-2 transmission risk factors.
Intensive health surveillance of close contracts of patients with COVID-19 provided a rare opportunity to determine asymptomatic attack rates and SARS-CoV-2 transmission risk factors.
One reason for the lack of antiviral therapies for COVID-19 is the paucity of knowledge about the β-Coronavirus-host cell interface, until now.
This detailed description of an institutional response to the COVID-19 pandemic in NYC highlights approaches that can be applied to help other hospitals plan for surges.
Study authors evaluated the performance of symptom-based definitions to detect influenza in a cohort of pregnant women in India, Peru, and Thailand.
Study authors analyzed microbiological data on COVID-19 patients to assess for bacterial co-infections associated with antimicrobial therapy.
Study authors assessed the association of piperacillin/tazobactam MIC, meropenem MIC, and beta-lactam resistance genes with mortality in the MERINO trial.
Study authors evaluated whether use of aspirin in hospitalized patients with COVID-19 was associated with reduced risk of mechanical ventilation, reduced risk for intensive care unit admission, and in-hospital mortality.
To facilitate harmonized evaluation and comparison of the efficacy of COVID-19 vaccines, study authors proposed a general set of clinical endpoints, along with considerations to guide the selection of primary endpoints.
Study authors assessed the effectiveness of high-dose influenza vaccines in patients with HIV during the 2017-2018 influenza season.
Study authors described the prescribing patterns in children with community-acquired pneumonia, and assessed the relationship between narrow-spectrum antibiotics, broad-spectrum antibiotics, and macrolides with clinical outcomes.